Divi's Laboratories Limited CC-Mar24.pdf · 2024-05-25
Congratulations on a standout quarter. I just have 2 questions. First is that if you can probably clarify to some extent if the current quarter's CS businesses has some benefit from pilot projects? And the second question is that when you're talking about increased inquiries, if you can probably speak about the kind of clients qualitatively. Are these small and mid-tier biotech companies who are wanting to shift projects on a short-term basis? Or are these large companies who are doing pilot testing with us?
So my first question is that if you can probably help me understand, in the CS business, was there any benefit of pilot project benefit in this particular quarter? And my second question is that qualitatively, if you can help me understand that the increased inquiries that you're getting from clients in the CS business probably because of the Biosecure act, are they largely small or mid-tier biotech companies? Or are these large companies who are wanting to look at our capabilities and then create long-term contracts with us?